Fresenius SE & Co KGaA (FRA:FRE) Given a €52.00 Price Target by Barclays Analysts

Barclays set a €52.00 ($60.47) price target on Fresenius SE & Co KGaA (FRA:FRE) in a research note issued to investors on Thursday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Warburg Research set a €65.00 ($75.58) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Thursday, July 11th. Credit Suisse Group set a €50.00 ($58.14) target price on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Monday, May 6th. JPMorgan Chase & Co. reissued a neutral rating on shares of SUZUKI MTR CORP/ADR in a research report on Wednesday, July 17th. Morgan Stanley reduced their target price on shares of Pure Storage from $22.00 to $21.00 and set an equal weight rating for the company in a research report on Wednesday, May 22nd. Finally, Berenberg Bank set a €70.95 ($82.50) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Thursday, May 2nd. Nine investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average price target of €58.70 ($68.26).

Shares of Fresenius SE & Co KGaA stock opened at €45.03 ($52.36) on Thursday. The company has a 50-day simple moving average of €46.87. Fresenius SE & Co KGaA has a 52-week low of €60.16 ($69.95) and a 52-week high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Recommended Story: Real Estate Investment Trust (REIT) ETF

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.